Moreover, the increase in cell growth arrest and G2/M phase arrest were partially alleviated by TM4SF1 overexpression in shB7-H3 CRC cells treated with low-dose DOX (Fig. 4F–H). Here, TM4SF1 is linked to colorectal carcinoma.